Xlife Sciences Equity 2024

Xlife Sciences Aktienanalyse

What does Xlife Sciences do?

Xlife Sciences AG is a company active in the field of biotechnology. The company was founded in 2017 and is based in Switzerland. The main activity of Xlife Sciences AG is the identification and development of biotechnology products, particularly in the field of health sciences. The business model of Xlife Sciences AG is based on collaborations with leading scientists and research groups worldwide. The company identifies promising research areas and takes on the financing and development of projects until they are marketable. Xlife Sciences AG works closely with academic environments, universities, research institutes, venture capital firms, and other partners. Xlife Sciences AG specializes in three main divisions: Human Health, Agrifood, and Industrial Biotechnology. Under the Human Health division, the company develops drugs and therapies for various diseases and health problems. These include cancer, diabetes, cardiovascular diseases, infectious diseases, and autoimmune diseases. The Agrifood division of Xlife Sciences AG works on innovative solutions for agriculture and food production. This includes the development of plants that are resistant to pests and drought, as well as the development of foods with functional properties such as increased nutritional value or improved durability. The Industrial Biotechnology division of Xlife Sciences AG focuses on the development of biotechnological products for industrial use. This includes biofuels made from renewable raw materials and the production of biobased materials such as plastics and textiles. An example of a product developed by Xlife Sciences AG is a new drug against cancer. This drug was developed in collaboration with the University of Basel and has the potential to revolutionize cancer treatment. The effectiveness of the drug has already been proven in animal tests, and preparations for clinical trials are underway. Overall, Xlife Sciences AG aims to develop innovative technologies and products that improve people's lives while also being economically successful. The company relies on close cooperation with scientists, investors, and industry partners. Xlife Sciences AG has established itself as an important player in the biotechnology industry and continuously works to expand its range of products and services. Although the company is relatively young, it already has numerous promising projects in the pipeline and strives to develop innovative solutions for the challenges of our time in the future. Xlife Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Xlife Sciences's Equity

Xlife Sciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Xlife Sciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Xlife Sciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Xlife Sciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Xlife Sciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Xlife Sciences stock

What is the equity of Xlife Sciences this year?

Xlife Sciences has equity of 268.17 M CHF this year.

What was the equity of Xlife Sciences compared to the previous year?

The equity of Xlife Sciences has increased/decreased by 14% increased compared to the previous year.

What impact does a high equity have on investors of Xlife Sciences?

A high equity is advantageous for investors of Xlife Sciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Xlife Sciences?

A low equity can be a risk for investors of Xlife Sciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Xlife Sciences affect the company?

An increase in equity of Xlife Sciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Xlife Sciences affect the company?

A reduction in equity of Xlife Sciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Xlife Sciences?

Some factors that can affect the equity of Xlife Sciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Xlife Sciences so important for investors?

The equity of Xlife Sciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Xlife Sciences take to change the equity?

To change equity, Xlife Sciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Xlife Sciences pay?

Over the past 12 months, Xlife Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xlife Sciences is expected to pay a dividend of 0 CHF.

What is the dividend yield of Xlife Sciences?

The current dividend yield of Xlife Sciences is .

When does Xlife Sciences pay dividends?

Xlife Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xlife Sciences?

Xlife Sciences paid dividends every year for the past 0 years.

What is the dividend of Xlife Sciences?

For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xlife Sciences located?

Xlife Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xlife Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xlife Sciences from 9/28/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Xlife Sciences pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Xlife Sciences in the year 2023?

In the year 2023, Xlife Sciences distributed 0 CHF as dividends.

In which currency does Xlife Sciences pay out the dividend?

The dividends of Xlife Sciences are distributed in CHF.